HEAD & NECK CANCERS

Latest News

Reduced-Dose RT Safe & Effective for Head & Neck Cancer, Lowering Toxicity
Reduced-Dose RT Safe & Effective for Head & Neck Cancer, Lowering Toxicity

April 28th 2025

Reduced-dose radiotherapy in head & neck cancer shows similar efficacy to standard dose but with lower toxicity, per findings from the UPGRADE-RT trial.

Keytruda Plus SOC: New Standard for Advanced Head & Neck Cancer
Keytruda Plus SOC: New Standard for Advanced Head & Neck Cancer

April 28th 2025

FDA Oks Penpulimab for First-Line Non-Keratinizing Nasopharyngeal Carcinoma
FDA Oks Penpulimab for First-Line Non-Keratinizing Nasopharyngeal Carcinoma

April 24th 2025

Neoadjuvant Nivolumab/Chemo Shows Promise in HPV-Negative HNSCC
Neoadjuvant Nivolumab/Chemo Shows Promise in HPV-Negative HNSCC

April 13th 2025

Palliative Care Consultations Enhance QOL, Reduce Costs in End-of-Life Esophageal Cancer Care
Palliative Care Consultations Enhance QOL, Reduce Costs in End-of-Life Esophageal Cancer Care

January 27th 2025

Video Series
Video Interviews

More News